CML is a myeloproliferative neoplasm characterized by a translocation between chromosomes (9, 22), resulting in a BCR‐ABL1 fusion gene with tyrosine kinase activity. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.